These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1687681)

  • 21. Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.
    Stockton ME; Rasmussen K
    Neuropsychopharmacology; 1996 Feb; 14(2):97-105. PubMed ID: 8822532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of prenatal cocaine exposure on spontaneously active midbrain dopamine neurons in adult male offspring: an electrophysiological study.
    Minabe Y; Ashby CR; Heyser C; Spear LP; Wang RY
    Brain Res; 1992 Jul; 586(1):152-6. PubMed ID: 1511345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depolarization inactivation of dopamine neurons: an artifact?
    Mereu G; Lilliu V; Vargiu P; Muntoni AL; Diana M; Gessa GL
    J Neurosci; 1995 Feb; 15(2):1144-9. PubMed ID: 7869090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y; Emori K; Ashby CR
    Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic treatment with high doses of haloperidol fails to decrease the time course for the development of depolarization inactivation of midbrain dopamine neurons.
    Jiang LH; Tsai M; Wang RY
    Life Sci; 1988; 43(1):75-81. PubMed ID: 3386416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1983 Aug; 3(8):1607-19. PubMed ID: 6135762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinazolinone cholecystokinin (CCK)-B antagonists decrease midbrain dopamine unit activity.
    Rasmussen K; Yu MJ; Czachura JF
    Synapse; 1994 Aug; 17(4):278-82. PubMed ID: 7992203
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.
    Olijslagers JE; Perlstein B; Werkman TR; McCreary AC; Siarey R; Kruse CG; Wadman WJ
    Eur J Pharmacol; 2005 Sep; 520(1-3):77-85. PubMed ID: 16154561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K; Suzuki K; McCreary AC; Ashby CR
    Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.
    Gueudet C; Santucci V; Rinaldi-Carmona M; Soubrié P; Le Fur G
    Neuroreport; 1995 Jul; 6(10):1421-5. PubMed ID: 7488739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons.
    Rasmussen K
    Ann N Y Acad Sci; 1994 Mar; 713():300-11. PubMed ID: 8185172
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute and subchronic effects of Rimcazole (BW 234U), a potential antipsychotic drug, on A9 and A10 dopamine neurons in the rat.
    Piontek JA; Wang RY
    Life Sci; 1986 Aug; 39(7):651-8. PubMed ID: 2874468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Neuropharmacology; 1986 Sep; 25(9):995-1001. PubMed ID: 2877417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
    Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of neurokinin3 receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs.
    Gueudet C; Santucci V; Soubrié P; Le Fur G
    Synapse; 1999 Jul; 33(1):71-9. PubMed ID: 10380852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated administration of Sigma ligands alters the population activity of rat midbrain dopaminergic neurons.
    Zhang J; Chiodo LA; Wettstein JG; Junien JL; Freeman AS
    Synapse; 1993 Mar; 13(3):223-30. PubMed ID: 8497808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons.
    White FJ; Wang RY
    Science; 1983 Sep; 221(4615):1054-7. PubMed ID: 6136093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of glucose on antipsychotic drug-induced changes in dopamine neuronal activity.
    Freeman AS; Weddige FK; Lipinski JL
    Eur J Pharmacol; 2001 Nov; 431(1):43-6. PubMed ID: 11716841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.